HOME >> MEDICINE >> NEWS
Co-occurring disorders increase risk of suicide attempt by adolescents

Research has shown that adolescents with substance use disorders are most likely to attempt suicide when they also have a co-occurring mood disorder. NIDA-funded scientists at the University of Pittsburgh have extended this research and found that generally, both male and female substance abusers who attempt suicide begin taking drugs at an early age and have more symptoms of psychiatric and substance use disorders than adolescents who do not attempt suicide.

Dr. Thomas Kelly and colleagues collected data from 188 females and 315 males, aged 12 to 19 years, who were diagnosed with an alcohol or substance use disorder and who participated in studies between 1991 and 2000 at the Pittsburgh Adolescent Alcohol Research Center. The adolescents completed standardized assessments of substanceand nonsubstance-related psychiatric disorders. Both the adolescents and their parents answered standardized questions about age of onset for all diagnosed psychiatric disorders. Adolescents who attempted suicide and their parents estimated the age(s) at which the adolescent attempted suicide.

Overall, 29 males and 56 females made one or more suicide attempts during their lifetimes. Males with hallucinogen use disorders, inhalant use disorders, sedative-hypnotic use disorders, and attention-deficit hyperactivity disorder were more likely to have attempted suicide than males who were not diagnosed with these disorders. Male suicide attempters had more symptoms of mood, alcohol, and disruptive behavior disorders compared with male nonattempters. There existed an earlier age of onset for alcohol use disorders and conduct disorders among male suicide attempters compared with the age of onset among males with these disorders who did not attempt suicide.

Females with conduct disorders and substance use disorders (other than cannabis use disorders) were at higher risk for attempting suicide than females who were not diagnosed with conduct disorders or noncannabis subst
'"/>

Contact: Blair Gately
bgately@nida.nih.gov
301-443-6245
NIH/National Institute on Drug Abuse
3-May-2004


Page: 1 2

Related medicine news :

1. New self-help technology set to combat eating disorders
2. Diagnostic test for range of blood disorders on the horizon
3. Dental practitioners can be instrumental in preventing their patients eating disorders
4. Psychiatric disorders greatly underdiagnosed in hospital emergency departments
5. Newly discovered virus linked to childhood lung disorders and Kawasaki disease
6. Drug to treat ADHD has similar effect on children with reading disorders
7. Gastrointestinal disorders are associated significantly with sleepless nights
8. Immigration & psychiatric disorders
9. Diabetics with mental disorders at increased risk for diabetic complications
10. Canadian researchers to develop smart drug to repair psychiatric disorders
11. Nicotine dependence & psychiatric disorders

Post Your Comments:
(Date:5/23/2013)... Jim Fitzpatrick just did it again. The ... outside-of-the-box approach to reaching the retail automotive industry. With ... to the retail automotive industry, blending the immediacy of ... format. , CBTNews.com is an innovative website covering ... and Russell Brown host the show with videos, news ...
(Date:5/23/2013)... Coral Springs, FL (PRWEB) May 23, 2013 ... segment about redefining retirement. Many Americans are facing a dim ... stated the Late Boomers -- those born after 1955 -- ... credit card debt. But all hope for The Golden Years ... about how to reduce debt and keep earning after reaching ...
(Date:5/23/2013)... can cause rapidly progressing, life threatening meningitis and meningococcal ... have not known how it attaches to the human ... attaches to the airway to colonise", People can be ... while some people progress to invasive disease. To ... how the bacterium colonises the airway. Now that the ...
(Date:5/23/2013)... HealthDay Reporter , , WEDNESDAY, May 22 (HealthDay News) -- ... detecting lung cancer now have more information to help with ... finds that low-dose CT scans pick up significantly more lung ... history of smoking are at high risk for lung cancer, ... doctors have to consider the potential harm of radiation exposure ...
(Date:5/23/2013)... Los Angeles,Ca (PRWEB) May 23, 2013 ... with removing every sign associated with Rosacea. This condition ... skin and can affect a person’s self-image. Manufacturers have ... work to help constrict blood vessels near the surface ... and flushing. The new formula is available with special ...
Breaking Medicine News(10 mins):Health News:Fitzpatrick Advertising Founder Brings Auto Industry into Focus with CBT News 2Health News:Viewpoints with Terry Bradshaw Presents a Series on Redefining Retirement 2Health News:New discovery in fight against deadly meningococcal disease 2Health News:CT Scans Reduce Lung Cancer Deaths, Study Confirms 2Health News:CT Scans Reduce Lung Cancer Deaths, Study Confirms 3Health News:Revitol Rosacea Now Comes with Anti-Inflammatory Ingredients to Remove Redness and Flushing 2
(Date:5/23/2013)... 2013  Omeros Corporation (NASDAQ: OMER ... Application (IND) to evaluate OMS824 in Huntington,s disease ... Drug Administration (FDA). OMS824 selectively inhibits phosphodiesterase 10 ... brain linked to a wide range of diseases ... OMS824 has shown promising results in animal models ...
(Date:5/23/2013)... -- Echo Pharma Acquisition Limited ("Royalty Pharma") announced today that ... from 90 percent to 50 percent of Maximum Elan ... the terms of the Revised Offer Document issued today, ... the terms of the Increased Offer, Royalty Pharma is ... for $12.50 per share in cash. The Increased Offer ...
(Date:5/23/2013)... Engeland, May 23, 2013 Nederland ... met lagere urinewegsymptomen geassocieerd met BPH Astellas ... dochteronderneming van Astellas Pharma Inc, gebaseerd in ... kondigde vandaag aan dat het Nederlandse College ter Beoordeling ... in Nederland. De handelsvergunning verleend voor VESOMNI ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 2Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 3Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 4
Cached News: